Home > Publications Database > Epigenetic gene expression links heart failure to memory impairment. > print

001     157715
005     20230915092350.0
024 7 _ |a 10.15252/emmm.201911900
|2 doi
024 7 _ |a pmid:33471428
|2 pmid
024 7 _ |a pmc:PMC7933944
|2 pmc
024 7 _ |a 1715-4684
|2 ISSN
024 7 _ |a 1757-4676
|2 ISSN
024 7 _ |a 1757-4684
|2 ISSN
024 7 _ |a altmetric:98050029
|2 altmetric
037 _ _ |a DZNE-2021-01172
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Islam, Rezaul
|0 P:(DE-2719)2811643
|b 0
|e First author
245 _ _ |a Epigenetic gene expression links heart failure to memory impairment.
260 _ _ |a Heidelberg
|c 2021
|b EMBO Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1657626854_13982
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a In current clinical practice, care of diseased patients is often restricted to separated disciplines. However, such an organ-centered approach is not always suitable. For example, cognitive dysfunction is a severe burden in heart failure patients. Moreover, these patients have an increased risk for age-associated dementias. The underlying molecular mechanisms are presently unknown, and thus, corresponding therapeutic strategies to improve cognition in heart failure patients are missing. Using mice as model organisms, we show that heart failure leads to specific changes in hippocampal gene expression, a brain region intimately linked to cognition. These changes reflect increased cellular stress pathways which eventually lead to loss of neuronal euchromatin and reduced expression of a hippocampal gene cluster essential for cognition. Consequently, mice suffering from heart failure exhibit impaired memory function. These pathological changes are ameliorated via the administration of a drug that promotes neuronal euchromatin formation. Our study provides first insight to the molecular processes by which heart failure contributes to neuronal dysfunction and point to novel therapeutic avenues to treat cognitive defects in heart failure patients.
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a cognition
|2 Other
650 _ 7 |a epigenetics
|2 Other
650 _ 7 |a heart failure
|2 Other
650 _ 7 |a histone
|2 Other
650 _ 7 |a memory impairment
|2 Other
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Cognition
|2 MeSH
650 _ 2 |a Epigenesis, Genetic
|2 MeSH
650 _ 2 |a Gene Expression
|2 MeSH
650 _ 2 |a Heart Failure: genetics
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Memory Disorders
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
700 1 _ |a Lbik, Dawid
|b 1
700 1 _ |a Sakib, M Sadman
|0 P:(DE-2719)2812054
|b 2
700 1 _ |a Maximilian Hofmann, Raoul
|b 3
700 1 _ |a Berulava, Tea
|0 P:(DE-2719)2811247
|b 4
700 1 _ |a Jiménez Mausbach, Martí
|0 P:(DE-2719)9002263
|b 5
|u dzne
700 1 _ |a Cha, Julia
|0 P:(DE-2719)9002258
|b 6
|u dzne
700 1 _ |a Goldberg, Maria
|0 P:(DE-2719)9001958
|b 7
700 1 _ |a Elerdashvili, Vakhtang
|0 P:(DE-2719)2811844
|b 8
700 1 _ |a Schiffmann, Christian
|0 P:(DE-2719)9002272
|b 9
|u dzne
700 1 _ |a Zieseniss, Anke
|b 10
700 1 _ |a Katschinski, Dörthe Magdalena
|0 0000-0003-4630-9081
|b 11
700 1 _ |a Sananbenesi, Farahnaz
|0 P:(DE-2719)2811099
|b 12
700 1 _ |a Toischer, Karl
|0 P:(DE-2719)9000440
|b 13
700 1 _ |a Fischer, Andre
|0 P:(DE-2719)2000047
|b 14
|e Last author
773 _ _ |a 10.15252/emmm.201911900
|g Vol. 13, no. 3
|0 PERI:(DE-600)2485479-7
|n 3
|p e11900
|t EMBO molecular medicine
|v 13
|y 2021
|x 1757-4684
856 4 _ |u https://www.embopress.org/doi/full/10.15252/emmm.201911900
856 4 _ |u https://pub.dzne.de/record/157715/files/19431.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/157715/files/19431.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:157715
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2811643
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2812054
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2811247
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)9002263
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)9002258
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)9001958
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)2811844
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)9002272
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 12
|6 P:(DE-2719)2811099
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 13
|6 P:(DE-2719)9000440
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 14
|6 P:(DE-2719)2000047
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 0
914 1 _ |y 2021
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-04
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-04
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2021-02-04
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-07-19T13:19:31Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-07-19T13:19:31Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review, Double blind peer review
|d 2021-07-19T13:19:31Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-29
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EMBO MOL MED : 2021
|d 2022-11-29
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b EMBO MOL MED : 2021
|d 2022-11-29
920 1 _ |0 I:(DE-2719)1410002
|k AG Fischer 1
|l Epigenetics and Systems Medicine in Neurodegenerative Diseases
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1410002
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21